The Glenmark Settlement Explained

Global drug manufacturer Glenmark Pharmaceuticals has agreed to pay $29.6 million to settle a lawsuit filed by dozens of states.

Healthcare Finance News reports that  Glenmark was accused of colluding with other companies to fix the  prices of generic prescription drugs sold nationwide. These increased  for medication needed for ailments ranging from cancer to ADHD by as  much as 1,000 percent, the New York State Attorney General’s Office states.